Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF study.

Source:http://linkedlifedata.com/resource/pubmed/id/20143449

Cancer 2010 Apr 1 116 7 1725-32

Download in:

View as

General Info

PMID
20143449